Zacks reaffirmed their neutral rating on shares of Johnson & Johnson (NYSE:JNJ) in a research note issued to investors on Thursday, Stock Ratings News reports. The firm currently has a $99.00 price target on the stock. Johnson & Johnson (NYSE:JNJ), stock opened at $92.12 in last session, and closed at $90.61, while the day range of stock is $90.61-$92.61. The stock showed a negative weekly performance of -4.26%.
A report released Wednesday by the pharmaceutical industry raises alarms over a rising gap between the United States and other countries on science, technology, engineering and math skills, while outlining what Eli Lilly and Co. (NYSE:LLY), and other companies are doing to help shrink the gap. Eli Lilly & Co. (NYSE:LLY), stock opened at $54.71, in last session and closed at $54.12, by losing -1.87%. The 52 week range of the stock is $47.53-$58.40. Company’s market capitalization is $60.97billion.
Zimmer Holdings, Inc. (NYSE:ZMH) had its target price lifted by Argus from $98.00 to $110.00 in a research note released on Thursday morning, AmericanBankingNews.com reports. They currently have a buy rating on the stock. Zimmer Holdings, Inc. (NYSE:ZMH), stock decreased -2.12% and finished the last session at $93.36. The EPS of the stock remained 3.94. Company’s market capitalization is $15.96billion.
Zacks reissued their neutral rating on shares of Abbott Laboratories (NYSE:ABT) in a research report released on Thursday morning, American Banking and Market News reports. Zacks currently has a $40.00 price objective on the stock. Abbott Laboratories (NYSE:ABT), stock opened the session at $37.20, and closed the session at $36.58. The 52 week range of the stock remained $32.70-$39.86 and the day range was $36.57-$37.20.
Leave a Reply